KEYNOTE-B96 is the first trial to show overall survival (OS) improvement with an immune checkpoint inhibitor-based treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback